We are live on ! Find out more
PM

Prosight Management Portfolio holdings

AUM $580M
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
-0.09%
1 Year Est. Return
+29.81%
3 Year Est. Return
+39.55%
5 Year Est. Return
-6.93%
10 Year Est. Return
–
AUM
$136M
AUM Growth
-$23M
Cap. Flow
-$16.5M
Cap. Flow %
-12.08%
Top 10 Hldgs %
63.07%
Holding
41
New
10
Increased
7
Reduced
14
Closed
10

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$7.82M
2
ATHN
Athenahealth, Inc.
ATHN
+$6.11M
3
INDP icon
Indaptus Therapeutics
INDP
+$5.57M
4
NGNE icon
Neurogene
NGNE
+$5.22M
5
KURA icon
Kura Oncology
KURA
+$4.88M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$18.4M
2
SBRA icon
Sabra Healthcare REIT
SBRA
+$9.4M
3
AFAM
Almost Family Inc
AFAM
+$7.56M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$6.54M
5
DXCM icon
DexCom
DXCM
+$4.82M

Sector Composition

Rank Sector Weight
1 Healthcare 93.5%
2 Industrials 4.81%
3 Real Estate 1.58%
4 Miscellaneous 0.12%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KZR
26
DELISTED
Kezar Life Sciences
KZR
$721K 0.53%
+4,169
New +$727K
NVLN
27
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$716K 0.52%
194,663
-38,340
-16% -$154K
CIVI
28
DELISTED
Civitas Solutions, Inc.
CIVI
$568K 0.42%
34,649
-129,747
-79% -$2.01M
CLLS
29
Cellectis
CLLS
$342M
$548K 0.4%
+19,388
New +$577K
AVEO
30
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$337K 0.25%
14,907
-89,448
-86% -$2.12M
AVEO
31
CALL
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$158K 0.12%
+7,010
New +$166K
DXCM icon
32
DexCom
DXCM
$34.3B
– –
-260,000
Closed -$4.82M
INGN icon
33
PUT
Inogen
INGN
$146M
– –
-26,800
Closed -$3.29M
QURE icon
34
uniQure
QURE
$3.38B
– –
-34,100
Closed -$801K
BLCM
35
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-10,605
Closed -$696K
CLVS
36
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-50,000
Closed -$2.64M
CLVS
37
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-46,001
Closed -$2.43M
QTNT
38
DELISTED
Quotient Limited Ordinary Shares
QTNT
– –
-17,055
Closed -$3.21M
AMPE
39
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
– –
-371
Closed -$378K
KND
40
DELISTED
Kindred Healthcare
KND
– –
-162,326
Closed -$1.49M
AFAM
41
DELISTED
Almost Family Inc
AFAM
– –
-135,000
Closed -$7.56M
1
2

Similar funds

SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
CCWM
Correct Capital Wealth Management Clayton, Missouri $580M AUM 16.45% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
RIS
Retirement Income Solutions Ann Arbor, Michigan $581M AUM 19.42% 1-Year Est. Return
MFS
McNamara Financial Services Marshfield, Massachusetts $580M AUM 17.89% 1-Year Est. Return
GFI
Global Frontier Investments Charleston, South Carolina $581M AUM 8.55% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return
CA
COFG Advisors Oak Brook, Illinois $579M AUM

Prosight Management's Q2 2018 Portfolio in Review

As of Q2 2018, Prosight Management held 41 positions worth $136M, down 14% from $159M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Prosight Management withdrew a net $16.5M in Q2 2018, closing 10 positions and reducing 14 holdings. Its most notable exit was Almost Family Inc, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 85% a quarter earlier, followed by Industrials and Real Estate.

Against the trend, Prosight Management opened a new position in Athenahealth, Inc. worth $6.55M.

  • Prosight Management's largest Q2 2018 buy was Athenahealth, Inc.: 41,193 shares worth $6.55M.
  • Prosight Management added most to Cigna in Q2 2018, an estimated $7.82M increase.
  • Prosight Management's biggest Q2 2018 reduction was Shire pic, cutting an estimated $18.4M.
  • Prosight Management fully exited Almost Family Inc in Q2 2018, selling an estimated $7.56M.
  • Prosight Management's ten largest holdings make up 63% of its $136M portfolio in Q2 2018.
  • Prosight Management opened 10 new positions and closed 10 in Q2 2018.
  • Prosight Management's portfolio value fell 14% quarter-over-quarter to $136M.

Based on Prosight Management's 13F filing for Q2 2018, filed 14 Aug 2018.